Nat. Med.

ISSN	1546-170X
ISSN-L	1078-8956
IUID	6efc0b2991e74ad5aa035146edd2461e
Modified	2020-11-27T13:14:05.134Z
Created	2017-05-09T09:12:08.353Z

Year 2026

PubMed DOI Crossref

Mapping the human chemical exposome for public health.

David A, Lennon S, Mercier F, ..., Le Bizec B, Samson M

Nat. Med. - (-) - [2026-03-18; online 2026-03-18]

Exposomics [Collaborative]

Year 2025

PubMed DOI Crossref

Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare.

Kämpe A, Gudmundsson S, Walsh CP, ..., Lindstrand A, Lappalainen T

Nat. Med. 31 (6) 1730-1732 [2025-06-00; online 2025-04-05]

Bioinformatics (NBIS) [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative] Clinical Genomics Gothenburg [Collaborative] Clinical Genomics Lund [Service] NGI Long read [Collaborative] NGI Uppsala (Uppsala Genome Center) [Collaborative] National Genomics Infrastructure [Collaborative]

PubMed DOI Crossref

Blood-based biomarkers of Alzheimer's disease and incident dementia in the community.

Grande G, Valletta M, Rizzuto D, ..., Fratiglioni L, Vetrano DL

Nat. Med. - (-) - [2025-03-26; online 2025-03-26]

Affinity Proteomics Stockholm [Collaborative]

PubMed DOI Crossref

Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis.

Scahill RI, Farag M, Murphy MJ, ..., Langbehn DR, Tabrizi SJ

Nat. Med. 31 (3) 807-818 [2025-03-00; online 2025-01-17]

Glycoproteomics and MS Proteomics [Service]

PubMed DOI Crossref

Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's disease.

Islam T, Hill E, Abrahamson EE, ..., Blennow K, Karikari TK

Nat. Med. 31 (2) 574-588 [2025-02-00; online 2025-02-10]

Integrated Microscopy Technologies Gothenburg [Service]

Year 2024

PubMed DOI Crossref

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

De Laere B, Crippa A, Discacciati A, ..., Grönberg H, Lindberg J

Nat. Med. 30 (11) 3291-3302 [2024-11-00; online 2024-08-20]

Bioinformatics (NBIS) [Collaborative] Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative] Clinical Genomics [Service] Clinical Genomics Stockholm [Service]

PubMed DOI Crossref

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.

Bojmar L, Zambirinis CP, Hernandez JM, ..., Jarnagin WR, Lyden D

Nat. Med. 30 (8) 2170-2180 [2024-08-00; online 2024-06-28]

Clinical Genomics [Service] Clinical Genomics Linköping [Service]

Year 2022

PubMed DOI Crossref

Implementing precision medicine in a regionally organized healthcare system in Sweden.

Fioretos T, Wirta V, Cavelier L, ..., Edsjö A, Rosenquist R

Nat. Med. 28 (10) 1980-1982 [2022-10-00; online 2022-09-20]

Clinical Genomics [Collaborative] Clinical Genomics Gothenburg [Collaborative] Clinical Genomics Linköping [Service] Clinical Genomics Stockholm [Collaborative] Clinical Genomics Umeå [Service] Clinical Genomics Uppsala [Collaborative]

Year 2021

PubMed DOI Crossref

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.

Muus C, Luecken MD, Eraslan G, ..., NHLBI LungMap Consortium , Human Cell Atlas Lung Biological Network

Nat. Med. 27 (3) 546-559 [2021-03-00; online 2021-03-02]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Immune determinants of COVID-19 disease presentation and severity.

Brodin P

Nat. Med. 27 (1) 28-33 [2021-01-00; online 2021-01-13]

Cellular Immunomonitoring [Collaborative]

Year 2020

PubMed DOI Crossref

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Bernard E, Nannya Y, Hasserjian RP, ..., Ogawa S, Papaemmanuil E

Nat. Med. 26 (10) 1549-1556 [2020-10-00; online 2020-08-03]

Clinical Genomics [Service] Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.

Tamborero D, Dienstmann R, Rachid MH, ..., Rodon J, Lehtiö J

Nat. Med. 26 (7) 992-994 [2020-07-00; online 2020-07-08]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Collaborative] Clinical Genomics Stockholm [Collaborative] Global Proteomics and Proteogenomics [Technology development]

Year 2019

PubMed DOI Crossref

A clonal expression biomarker associates with lung cancer mortality.

Biswas D, Birkbak NJ, Rosenthal R, ..., Swanton C, TRACERx Consortium

Nat. Med. 25 (10) 1540-1548 [2019-10-00; online 2019-10-07]

Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]

PubMed DOI Crossref

Gain-of-function mutation of microRNA-140 in human skeletal dysplasia.

Grigelioniene G, Suzuki HI, Taylan F, ..., Sharp PA, Kobayashi T

Nat. Med. 25 (4) 583-590 [2019-04-00; online 2019-02-25]

Clinical Genomics [Service] Clinical Genomics Stockholm [Service] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Year 2018

PubMed DOI Crossref

CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.

Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J

Nat. Med. 24 (7) 927-930 [2018-07-00; online 2018-06-11]

CRISPR Functional Genomics [Collaborative] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service] Protein Science Facility (PSF) [Service]

PubMed DOI Crossref

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

Roswall P, Bocci M, Bartoschek M, ..., Eriksson U, Pietras K

Nat. Med. 24 (4) 463-473 [2018-05-00; online 2018-03-12]

Clinical Genomics [Service] Clinical Genomics Lund [Service]

Year 2017

PubMed DOI Crossref

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.

Davies H, Glodzik D, Morganella S, ..., Stratton MR, Nik-Zainal S

Nat. Med. 23 (4) 517-525 [2017-04-00; online 2017-03-13]

Clinical Genomics [Collaborative] Clinical Genomics Lund [Collaborative]

PubMed DOI Crossref

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Herold N, Rudd SG, Ljungblad L, ..., Helleday T, Schaller T

Nat. Med. 23 (2) 256-263 [2017-02-00; online 2017-01-09]

Chemical Biology Consortium Sweden [Collaborative] Protein Science Facility (PSF) [Service]

Year 2015

PubMed DOI Crossref

Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Vizoso M, Ferreira HJ, Lopez-Serra P, ..., Marais R, Esteller M

Nat. Med. 21 (7) 741-750 [2015-07-00; online 2015-06-01]

Tissue Profiling [Collaborative]

Year 2011

PubMed DOI Crossref

Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

D'Arcy P, Brnjic S, Olofsson MH, ..., Larsson R, Linder S

Nat. Med. 17 (12) 1636-1640 [2011-11-06; online 2011-11-06]

Array and Analysis Facility